The Acetaminophen Tablets, cataloged under National Stock Number 6505-01-075-3175, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is The Harvard Drug Group, L.l.c. Dba the Harvard Drug Group, L.l.c Div Major Pharmaceuticals & Rugby Laboratories. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-075-3175 |
| Primary Part Number | NDC00904-6720-59 |
| Item Name | Acetaminophen Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | The Harvard Drug Group, L.l.c. Dba the Harvard Drug Group, L.l.c Div Major Pharmaceuticals & Rugby Laboratories |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 500.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00904-6720-59 PRIMARY | The Harvard Drug Group, L.l.c. Dba the Harvard Drug Group, L.l.c Div Major Pharmaceuticals & Rugby Laboratories (USA) |
| NDC54738-0540-01 PRIMARY | Richmond Pharmaceuticals, Inc. (USA) |
NSN 6505-01-075-3175 is a Acetaminophen Tablets, manufactured by The Harvard Drug Group, L.l.c. Dba the Harvard Drug Group, L.l.c Div Major Pharmaceuticals & Rugby Laboratories, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-075-3175 has 2 manufacturer part numbers on file: NDC00904-6720-59 (The Harvard Drug Group, L.l.c. Dba the Harvard Drug Group, L.l.c Div Major Pharmaceuticals & Rugby Laboratories), NDC54738-0540-01 (Richmond Pharmaceuticals, Inc.).
Key specifications for NDC00904-6720-59: Administration: ORAL; Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.